Koi provides this information for research context only
Over-the-counter docusate sodium (Colace) at 100mg twice daily or polyethylene glycol (MiraLAX) can provide relief within 12-72 hours for medication-induced constipation
At 428.202(c)(4), we finalized that, notwithstanding 428.202(c)(2), for a subsequently approved drug for which there are no quarters during the first calendar year beginning after the drug's first marketed date for which AMP has been reported under section 1927(b)(3) of the Act for the NDC-9, including information as set forth in 428.202(d)(3), the payment amount benchmark period is the first calendar year in which such NDC-9 has at least 1 quarter of AMP reported
Urgent policy consideration of affordability and access, coupled with strategies to improve treatment persistence, is essential if these therapies are to meaningfully impact Polands obesity burden.
Building healthy habits alongside your medication not only helps minimize side effects but also creates the foundation for long-term, sustainable weight loss
Section 1848(p)(3) of the Act provides that costs shall be evaluated, to the extent practicable, based on a composite of appropriate measures of costs established by the Secretary that eliminate the effect of geographic adjustments in payment rates, and take into account risk factors (such as socioeconomic and demographic characteristics, ethnicity, and health status of individuals) and other factors determined appropriate by the Secretary